24 HR Glipizide 10 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Actavis Pharma, Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] blood glucose increased` `[4] toxicity to various agents` `[5] completed suicide` `[6] drug hypersensitivity` `[7] drug abuse` `[8] diarrhoea` `[9] fatigue` `[10] vomiting`

5 years ago

ROUND WHITE WPI 845

5 years ago

WPI 845 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

GLIPIZIDE Extended-Release Tablets are supplied as 2.5 mg, 5 mg, and 10 mg round, unscored, film-coated tablets and are printed with black ink as follows: 2.5 mg tablets are light orange and printed with “ WPI ” and “ 900 ”. They are available in the following package size: Bottles of 30 NDC 0591-0900-30 5 mg tablets are orange and printed with “ WPI ” and “ 844 ”. They are available in the following package sizes: Bottles of 100 NDC 0591-0844-01 Bottles of 1000 NDC 0591-0844-10 10 mg tablets are white to off-white and printed with “ WPI ” and “ 845 ”. They are available in the following package sizes: Bottles of 100 NDC 0591-0845-01 Bottles of 1000 NDC 0591-0845-10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture and humidity.

More pills like ROUND WPI 845

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

24 HR Glipizide 10 MG Extended Release Oral Tablet

FDA Reported Adverse Reactions [1] drug ineffective [2] nausea [3] blood glucose increased [4] toxicity to various agents [5] completed suicide [6] drug hypersensitivity [7] drug abuse [8] diarrhoea [9] fatigue [10] vomiting

ROUND WHITE WPI 845

WPI 845 ROUND WHITE

More pills like ROUND WPI 845

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] blood glucose increased` `[4] toxicity to various agents` `[5] completed suicide` `[6] drug hypersensitivity` `[7] drug abuse` `[8] diarrhoea` `[9] fatigue` `[10] vomiting`